Sep. 27, 2012 (China Knowledge) - The United Laboratories International Holdings Ltd<3933
> has posted HK$169.12 million-net profit for the first half of this year, reflecting a YoY decrease of 45%.
Basic earnings per share for the six-month period were 11.4 HK cents, and no dividend was declared.
According to a statement filed with Hong Kong Stock Exchange
, the company saw its revenue grow 8.1% YoY to HK$3.65 billion during the period, while the cost of sales for the six-month period surged 18.48% YoY to HK$2.58 billion.
Revenue from the sales of intermediate products decreased 11.35% YoY to HK$815.34 million during the six-month period, while that from the sales of bulk medicine and antibiotics finished products rose 20.98% and 7.11% YoY to HK$1.77 billion and HK$1.07 billion, respectively.